Table 1 Sialon II study participants by study site, testing history and measured HIV status after exclusion of participants already known to have HIV and with indeterminate HIV status knowledge
city | HIV negative (n) | percentage tested for HIV in the last 12 months (%) | undiagnosed HIV infection (n) | percentage with undiagnosed HIV (%) | undiagnosed HIV, negative HIV pre-test within recent 12 months (n) | undiagnosed HIV infection, no pre-test or test longer ago than 12 months (n) | percentage of undiagnosed HIV that may not be recent (%) | Total (N) |
|---|---|---|---|---|---|---|---|---|
Barcelona | 334 | 66.2% | 21 | 5.9% | 16 | 5 | 23.8% | 355 |
Bratislava | 376 | 35.5% | 15 | 3.8% | 6 | 9 | 60.0% | 391 |
Brighton | 331 | 56.7% | 15 | 4.3% | 10 | 5 | 33.3% | 346 |
Brussels | 327 | 63.5% | 7 | 2.1% | 5 | 2 | 28.6% | 334 |
Bucharest | 146 | 42.9% | 15 | 9.3% | 7 | 8 | 53.3% | 161 |
Hamburg | 336 | 52.1% | 15 | 4.3% | 11 | 4 | 26.7% | 351 |
Lisbon | 300 | 63.8% | 29 | 8.8% | 23 | 6 | 20.7% | 329 |
Ljubljana | 329 | 50.9% | 7 | 2.1% | 5 | 2 | 28.6% | 336 |
Sofiaa | 344 | 12 | 3.4% | 356 | ||||
Stockholm | 334 | 49.9% | 3 | 0.9% | 2 | 1 | 33.3% | 337 |
Verona | 367 | 41.9% | 10 | 2.7% | 2 | 8 | 80.0% | 377 |
Vilnius | 314 | 38.9% | 5 | 1.6% | 2 | 3 | 60.0% | 319 |
Warsaw | 346 | 57.9% | 22 | 6.0% | 17 | 5 | 22.7% | 368 |
Total | 4184 | 176 | 4.0% | 4360 | ||||
Total w/o Sofia | 3840 | 51.9% | 164 | 106 | 58 | 33.0% | 4004 |